期刊
ARCHIVES OF MEDICAL SCIENCE
卷 17, 期 5, 页码 1200-1212出版社
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/aoms.2019.88558
关键词
obstructive sleep apnoea; chronic intermittent hypoxia; atherosclerosis
With the increasing prevalence of obesity globally, obstructive sleep apnoea (OSA) is on the rise, leading to chronic intermittent hypoxia (CIH) which is considered a risk factor for atherosclerosis. While most risk factors for atherosclerosis are well understood, factors like CIH are less explored in their association with the disease.
As obesity becomes more common worldwide, the prevalence of obstructive sleep apnoea (OSA) continues to rise. Obstructive sleep apnoea is a wellknown disorder that causes chronic intermittent hypoxia (CIH), which is considered a risk factor for atherosclerosis directly and indirectly. Ischaemic heart disease remains the leading cause of death. Most risk factors for atherosclerosis are well understood. However, other factors such as CIH are less well understood. Several studies have investigated the pathophysiology of CIH, attempting to uncover its link to atherosclerosis and to determine whether OSA treatment can be a therapeutic modality to modify the risk for atherosclerosis. In this article, we will review the pathophysiology of OSA as an independent risk factor for cardiovascular disease and discuss the most common markers that have been studied. We will also examine the potential impact of OSA management as a risk factor modifier on the reversibility of atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据